Study of BGB-11417 in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

NCT05479994 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

100

Enrollment

INDUSTRY

Sponsor class

Conditions

Leukemia
Lymphoma
Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Small Lymphocytic Lymphoma
Relapsed Chronic Lymphocytic Leukemia

Interventions

DRUG: BGB-11417

Sponsor

BeiGene